|
|
|
Pharmaceutical Manufacturing and Packing Sourcer
|
Regardless of the many medicines available for treating numerous conditions, a significant problem for healthcare systems worldwide is that patients often do not reliably take treatments as intended. Poor adherence is detrimental to both the patient and their doctor – the patient’s wellbeing does not improve, which leads to further demands on healthcare professionals. Consequently, making medicines and medical devices more patient-centric has become a key objective for the industry.
Some of the main reasons for poor compliance are forgetfulness and a lack of understanding of the instructions, particularly for the elderly. As a result, many new patientcentric initiatives involve clearer directions and ways to remind the user to take their medicines.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
News and Press Releases |
 |
European Commission Approves BYANNLI® (6-monthly Paliperidone Palmitate; PP6M) for the Maintenance Treatment of Schizophrenia in Adults
BYANNLI® (6-monthly paliperidone palmitate; PP6M) is the first long-acting
injectable schizophrenia treatment to be approved with a twice-yearly dosing regimen[1] . The approval is based on results from the Route 6 Study,
which showed that 92.5 percent of patients treated with PP6M were relapse-free at
the end of the 12-month double-blind phase1.
More info >> |
|
 |
White Papers |
 |
|
A Rules Based Approach to Labelling and Artwork Management
Kallik
Many organisations today are experiencing unprecedented demands from regulatory authorities and consumers alike for product labelling to be made clearer and more informative. Forthcoming regulations (including the new EU MDR regulations coming into force May 2020) also require that labelling content to be published electronically in addition to print. As companies seek to continuously differentiate themselves in established markets as well as gain entry into new territories, the increase in both volume and complexity of product and market variations will have a direct impact on labelling.
More info >> |
|
|
